Orinator 20 Tablet contains Torasemide 20 mg, a potent loop diuretic indicated for the management of edema associated with congestive heart failure, renal impairment, and hepatic cirrhosis. Torasemide acts by inhibiting the sodium-potassium-chloride co-transporter in the thick ascending limb of the loop of Henle, promoting increased excretion of sodium, chloride, and water, thereby reducing fluid overload. This pharmacological action results in decreased blood volume and reduced preload, which can alleviate symptoms such as swelling and breathlessness. Orinator 20 is also employed in the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents, due to its ability to lower blood pressure by reducing plasma volume. The onset of diuretic effect typically occurs within one hour, with a duration of action lasting up to 12 hours. Caution is advised in patients with electrolyte imbalances, renal dysfunction, or hypersensitivity to sulfonamides. Monitoring of serum electrolytes, renal function, and blood pressure is recommended during therapy to prevent adverse effects such as hypokalemia, dehydration, or hypotension. Orinator 20 should be used under medical supervision, with dosage adjustments based on clinical response and patient tolerance.